http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-003175-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ff2d78578d95d1e8d3a2233c76188d |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
filingDate | 1996-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1998-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AR-003175-A1 |
titleOfInvention | A PHARMACEUTICAL COMPOSITION COMPRISING A PHARMACEUTICALLY ACCEPTABLE CARRIER AND A CHEMOTHERAPEUTICAL AGENT AND A TRIAZOL, SUCH A PHARMACEUTICAL COMPOSITION, WHICH INCLUDES A POTENTIAL, 1-POTENTIAL USE BY A CHEMICAL DRIVER, AND USE AND SAID TRIAZOLE TO TREAT CANCER, TUMORS OR VIRAL INFECTIONS IN MAMMALS OF HOT BLOOD |
abstract | A pharmaceutical composition for the treatment of cancers and tumors in mammals is presented, comprising 2- (2,4-difluorophenyl) -1,3-bis (1H-1,2,4-triazol-1-yl) propan-2 -ol and its derivatives. Together with 2- (2,4-difluorophenyl) -1,3-bis) 1H-1,2,4-triazol-1-yl) propan-2-ol and its derivatives, a chemotherapeutic agent can be used, as well as potentiators. . 2- (2,4-Difluorophenyl) -1,3-bis (1H-1,2,4-triazol-1-yl) propan-2-ol and its derivatives can also be used for the treatment of viral infections, either alone or in combination with other antiviral agents or with a booster. |
priorityDate | 1995-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.